Follow
Weiyi Peng
Weiyi Peng
Verified email at central.uh.edu
Title
Cited by
Cited by
Year
Loss of PTEN promotes resistance to T cell–mediated immunotherapy
W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ...
Cancer discovery 6 (2), 202-216, 2016
12972016
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma
DT Frederick, A Piris, AP Cogdill, ZA Cooper, C Lezcano, CR Ferrone, ...
Clinical cancer research 19 (5), 1225-1231, 2013
9582013
Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function
G Peng, Z Guo, Y Kiniwa, KS Voo, W Peng, T Fu, DY Wang, Y Li, ...
Science 309 (5739), 1380-1384, 2005
9532005
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Y Hailemichael, Z Dai, N Jaffarzad, Y Ye, MA Medina, XF Huang, ...
Nature medicine 19 (4), 465-472, 2013
4642013
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines
W Peng, C Liu, C Xu, Y Lou, J Chen, Y Yang, H Yagita, WW Overwijk, ...
Cancer research 72 (20), 5209-5218, 2012
4582012
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer
Y Kiniwa, Y Miyahara, HY Wang, W Peng, G Peng, TM Wheeler, ...
Clinical cancer research 13 (23), 6947-6958, 2007
4492007
Tumor-infiltrating γδ T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway
G Peng, HY Wang, W Peng, Y Kiniwa, KH Seo, RF Wang
Immunity 27 (2), 334-348, 2007
4352007
Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy
T Cascone, JA McKenzie, RM Mbofung, S Punt, Z Wang, C Xu, ...
Cell metabolism 27 (5), 977-987. e4, 2018
4282018
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice
C Liu, W Peng, C Xu, Y Lou, M Zhang, JA Wargo, JQ Chen, HS Li, ...
Clinical cancer research 19 (2), 393-403, 2013
3872013
CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
L Chen, L Diao, Y Yang, X Yi, BL Rodriguez, Y Li, PA Villalobos, ...
Cancer discovery 8 (9), 1156-1175, 2018
3412018
Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses
W Peng, Y Ye, BA Rabinovich, C Liu, Y Lou, M Zhang, M Whittington, ...
Clinical Cancer Research 16 (22), 5458-5468, 2010
2242010
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
J Zhao, X Wen, L Tian, T Li, C Xu, X Wen, MP Melancon, S Gupta, B Shen, ...
Nature communications 10 (1), 899, 2019
1972019
Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications
GM Fischer, YN Vashisht Gopal, JL McQuade, W Peng, RJ DeBerardinis, ...
Pigment cell & melanoma research 31 (1), 11-30, 2018
1592018
Tumor-associated galectin-3 modulates the function of tumor-reactive T cells
W Peng, HY Wang, Y Miyahara, G Peng, RF Wang
Cancer research 68 (17), 7228-7236, 2008
1522008
Development of immunotherapy combination strategies in cancer
TA Yap, EE Parkes, W Peng, JT Moyers, MA Curran, HA Tawbi
Cancer discovery 11 (6), 1368-1397, 2021
1202021
Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice
S Han, K Yang, Z Ozen, W Peng, E Marinova, G Kelsoe, B Zheng
The Journal of Immunology 170 (3), 1267-1273, 2003
1182003
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
RM Mbofung, JA McKenzie, S Malu, M Zhang, W Peng, C Liu, I Kuiatse, ...
Nature communications 8 (1), 451, 2017
1132017
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
G Han, G Yang, D Hao, Y Lu, K Thein, BS Simpson, J Chen, R Sun, ...
Nature communications 12 (1), 5606, 2021
832021
The RNA-binding protein MEX3B mediates resistance to cancer immunotherapy by downregulating HLA-A expression
L Huang, S Malu, JA McKenzie, MC Andrews, AH Talukder, T Tieu, ...
Clinical Cancer Research 24 (14), 3366-3376, 2018
812018
Anti-tumor activity mediated by CpG: the route of administration is critical
Y Lou, C Liu, G Lize, W Peng, C Xu, Y Ye, BA Rabinovich, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 34 (3), 279, 2011
802011
The system can't perform the operation now. Try again later.
Articles 1–20